These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29795527)

  • 21. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of three-times-per-week versus on-demand tadalafil treatment on erectile function and continence recovery following bilateral nerve sparing radical prostatectomy: results of a prospective, randomized, and single-center study.
    Canat L; Güner B; Gürbüz C; Atış G; Çaşkurlu T
    Kaohsiung J Med Sci; 2015 Feb; 31(2):90-5. PubMed ID: 25645987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of low-dose tadalafil in patients undergoing hemodialysis with end-stage renal disease.
    Bolat MS; Özer İ; Cinar O; Akdeniz E; Aşcı R
    Ren Fail; 2017 Nov; 39(1):582-587. PubMed ID: 28742406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy.
    Hirik E; Bozkurt A; Karabakan M; Onuk Ö; Balcı MB; Aydın M; Çakan M; Nuhoglu B
    Arch Ital Urol Androl; 2016 Mar; 88(1):4-6. PubMed ID: 27072168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome.
    Park MG; Yeo JK; Cho DY; Kim JW; Kim JW; Oh MM; Kim JJ; Moon du G
    J Sex Med; 2015 Apr; 12(4):966-74. PubMed ID: 25648342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses.
    Peng Z; Yang L; Dong Q; Wei Q; Liu L; Yang B
    Urol Int; 2017; 99(3):343-352. PubMed ID: 28628914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of daily tadalafil on reported outcomes in patients with erectile dysfunction and depressive symptoms: STROBE, a case-control study.
    Kim KS; Jeong TY; Moon HS
    Medicine (Baltimore); 2020 Jun; 99(23):e20546. PubMed ID: 32502017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of low-intensity shockwave therapy with different tadalafil regimens in patients with PDE5 inhibitor-resistant erectile dysfunction: a retrospective cohort study.
    İbis MA; Ozkaya F; Tokatli Z; Akpinar C; Yaman O
    Int Urol Nephrol; 2024 Feb; 56(2):407-413. PubMed ID: 37751053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy and safety of 5-mg once-daily versus 5-mg alternate-day tadalafil in men with erectile dysfunction and lower urinary tract symptoms.
    Choi H; Kim JH; Shim JS; Park JY; Kang SH; Moon DG; Cheon J; Lee JG; Kim JJ; Bae JH
    Int J Impot Res; 2015; 27(1):33-7. PubMed ID: 24990200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the intracavernosal injection platelet-rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non-responding to on-demand oral PDE5 inhibitors.
    Zaghloul AS; El-Nashaar AM; Said SZ; Osman IA; Mostafa T
    Andrologia; 2022 Jul; 54(6):e14421. PubMed ID: 35301742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tadalafil - a therapeutic option in the management of BPH-LUTS.
    Carson CC; Rosenberg M; Kissel J; Wong DG
    Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tadalafil Once a Day for Men with Erectile Dysfunction: Is It Superior than On-Demand Administration?
    Prasetyo DT; Raharja PAR; Mantiri BJ; Ringoringo DRL; Rahman IA; Felizio J; Tambunan MP; Fadhly SF; Rahardjo HE
    Acta Med Indones; 2019 Jul; 51(3):275-281. PubMed ID: 31699953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.
    Liguori G; Trombetta C; De Giorgi G; Pomara G; Maio G; Vecchio D; Ocello G; Ollandini G; Bucci S; Belgrano E
    J Sex Med; 2009 Feb; 6(2):544-52. PubMed ID: 19138360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.
    Bechara A; Romano S; Casabé A; Haime S; Dedola P; Hernández C; Rey H
    J Sex Med; 2008 Sep; 5(9):2170-8. PubMed ID: 18638006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study.
    Buvat J; Hatzichristou D; Boess FG; Büttner H; Gehchan N; Henneges C; Porst H
    Int J Clin Pract; 2014 Sep; 68(9):1087-99. PubMed ID: 25123817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized, open-label trial.
    Jiang H; Zhao LM; Lin HC; Yan S; Liu JH; Zhu ZH; Luo JD; Dai YT; Li FB; Lou Y; Zhang ZC
    Asian J Androl; 2018; 20(6):587-592. PubMed ID: 30004039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.